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Abstract
Background: Whether information from clinical trial registries (CTRs) and published randomised controlled trial
(RCTs) differs remains unknown. Knowing more about discrepancies should alert those who rely on RCTs for
medical decision-making to possible dissemination or reporting bias. To provide help in critically appraising
research relevant for clinical practice we sought possible discrepancies between what CTRs record and paediatric
RCTs actually publish. For this purpose, after identifying six reporting domains including funding, design, and
outcomes, we collected data from 20 consecutive RCTs published in a widely read peer-reviewed paediatric journal
and cross-checked reported features with those in the corresponding CTRs.
Methods: We collected data for 20 unselected, consecutive paediatric RCTs published in a widely read peer-reviewed
journal from July to November 2013. To assess discrepancies, two reviewers identified and scored six reporting
domains: funding and conflict of interests; sample size, inclusion and exclusion criteria or crossover; primary and
secondary outcomes, early study completion, and main outcome reporting. After applying the Critical Appraisal Skills
Programme (CASP) checklist, five reviewer pairs cross-checked CTRs and matching RCTs, then mapped and coded the
reporting domains and scored combined discrepancy as low, medium and high.
Results: The 20 RCTs were registered in five different CTRs. Even though the 20 RCTs fulfilled the CASP general criteria
for assessing internal validity, 19 clinical trials had medium or high combined discrepancy scores for what the 20 RCTs
reported and the matched five CTRs stated. All 20 RCTs selectively reported or failed to report main outcomes, 9 had
discrepancies in declaring sponsorship, 8 discrepancies in the sample size, 9 failed to respect inclusion or exclusion
criteria, 11 downgraded or modified primary outcome or upgraded secondary outcomes, and 13 completed early
without justification. The CTRs for seven trials failed to index automatically the URL address or the RCT reference, and
for 12 recorded RCT details, but the authors failed to report the results.
Conclusions: Major discrepancies between what CTRs record and paediatric RCTs publish raise concern about what
clinical trials conclude. Our findings should make clinicians, who rely on RCT results for medical decision-making, aware
of dissemination or reporting bias. Trialists need to bring CTR data and reported protocols into line with published data.
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Background
An emerging problem that has rarely been investigated
concerns the human factors that undermine clinical ran-
domised controlled trials (RCTs) at various stages [1]. In
the 1920s and 1930s two scientists in different research
fields [2, 3] helped enormously to reappraise statistical
theory and methodology in designing trials, thus clarify-
ing how bias influences research. Previous papers have
already compared protocols and registered data for
clinical outcomes in published RCTs in various clinical
settings [4–7], and three studies have investigated dis-
crepancies in selectively reported outcomes [8, 9]. Even
though concealment and blinding tools can control hu-
man factors in RCT designs [10] and the International
Committee of Medical Journal Editors (ICMJE) [11] and
Consolidated Standards of Reporting Trials (CONSORT)
[12] receive wide consensus, a recent survey among
journal editors endorsing the ICMJE and CONSORT
established policies disclosed that only 27 % of the 33
respondents cross-checked the data reported in the sub-
mitted manuscript against the data registered prospect-
ively in clinical trial registries (CTRs) [13]. In recent
years the Food and Drug Administration (FDA) ex-
panded the regulatory requirements for conducting clin-
ical trials and the truthfulness of the data submitted, and
now requires authors to annually update CTRs, thus
providing clear informative results [14]. Whether trial
design, conduction and outcome data from the various
CTRs and published RCTs differ or are incompletely re-
ported remains unknown [4, 15, 16]. One systematic re-
view assessed primary outcome discrepancies [17]. No
studies have analysed trial reporting domains more
widely, and none have addressed paediatric trials. Apart
from the Critical Appraisal Skills Programme (CASP)
checklist [18], nor do paediatricians and clinical re-
searchers have tools for assessing discrepancies and risk
of bias that compare what clinical researchers record in
the registered study hypothesis and protocol, and what
they then publish in RCTs [19–23]. Knowing more about
trial discrepancies should alert paediatricians, clinical re-
searchers, peer-reviewers, editors, and policymakers to
possible dissemination or reporting bias undermining
paediatric trials whose results provide the best informa-
tion for medical care [24].
To help in critically appraising research relevant for
clinical practice we sought possible discrepancies between
what CTRs record and paediatric RCTs actually publish.
For this purpose, after identifying six reporting domains,
including funding, design, and outcomes, we collected
data from a sample of 20 unselected consecutive RCTs
published in a widely read peer-reviewed paediatric jour-
nal and cross-checked reported features with those in the
corresponding CTRs.
Methods
In a study conducted from November 2012 to January
2016, to seek possible discrepancies between what CTRs
record and paediatric RCTs actually publish, two re-
viewers, an experienced clinical paediatrician and an
experienced researcher (PR and RD), identified six major
reporting domains: five based on their long experience
in critically appraising well-conducted clinical trials
(reported funding and conflict of interest incompletely
declared; discrepant or unclear sample size; inclusion
and exclusion criteria not being respected or selective
crossover; primary outcome downgraded and secondary
outcomes upgraded and reported as primary outcomes
in the publication; early study completion unjustified),
and one domain (main outcome selectively reported or
unreported) based on the Cochrane risk of bias tool [23,
24]. Over the first year they developed, assessed, and
graded CTR-RCT discrepancy scores. Over the ensuing
years five investigator pairs, supervised by two tutors
(PR and RD), and attending the annual course held at
Bambino Gesù Children’s Hospital, and subsequent
weekly meetings on critically appraising scientific publi-
cations (G.A.L.I.L.E.O.), carefully read the 20 consecutive
RCTs published monthly from July to November 2013 in
the journal Pediatrics [25–44]. They then searched the
CTR web link for each corresponding CTR, assessed
details, and ‘history of changes’ after the initial regis-
tration, and critically appraised each published RCT
with the CASP checklist. The five investigator pairs
then independently mapped and coded inconsisten-
cies for each reporting domain in the 20 trials, and
repeatedly searched online (last access 20 January
2016) from the corresponding CTR websites: the
United States National Institute of Health (NCT)
(https://clinicaltrials.gov), the International Standard
Randomised Controlled Trial Number (ISRCTN)
(currently BioMed Central Open Access publishers) (http://
www.isrctn.com/), the Nederlands Trials Register (NTR)
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(http://www.trialregister.nl/trialreg/index.asp), the Austra-
lian and New Zealand Clinical Trial Registry
(ACTRN), (http://www.anzctr.org.au) and the Clinical
Trial Registry-India (CTRI) (http://ctri.nic.in/Clinical-
trials/login.php). Meanwhile, PR and RD supervised
the five investigator pairs for scoring the six individ-
ual reporting domains and combined scores. PR and
RD then consulted the external tutor (FP), and con-
flicting interpretations were resolved by consensus. PR
and RD with the five investigator pairs then reas-
sessed inconsistencies between CTRs and RCTs for
each trial over 2 months and, after several attempts,
reached 100 % final agreement on grading discrepancy
scores from 1 to 3 points, according to the reporting
domain importance, and on grading combined dis-
crepancy scores as low, medium and high (Table 1,
Additional file 1). Higher discrepancy scores suggested
risk of bias.
Results
When we compared what the 20 paediatric RCTs pub-
lished in the journal Pediatrics reported and what the
collected five matching cross-checked CTRs recorded, 9
trials had medium (5–9) and 10 high (10–14) combined
discrepancy scores (Table 1, Additional file 1). The five
investigator pairs who critically appraised the trials with
the CASP checklist found that all 20 published RCTs
fulfilled the general criteria for assessing trial internal
validity. Of the 20 RCTs, 11 were registered in the
NCT [25, 26, 30, 32, 34–39, 44], 4 in the ISRCTN
[27, 29, 31, 43], 2 in the ACTRN [33, 42], 1 in the
NTR [28], 1 was registered both in the NTR and in
the ACTRN [40], and 1 in the CTRI [41]. Assessment
for the reporting domains disclosed that 9 trials had
discrepancies in declaring sponsorship and conflict of
interests [25, 33–37, 40, 41, 44], 8 trials had a dis-
crepant or unclear sample size [26, 31–33, 40–43], 9
trials failed to respect inclusion or exclusion criteria
[27, 28, 30, 34, 38–41, 44], 11 trials downgraded or
modified primary outcome measures or upgraded sec-
ondary outcomes [30, 33, 35–39, 41–44], 13 trials
completed early [29, 31, 32, 34–40, 42–44], and all 20
paediatric clinical trials selectively misreported outcomes
or failed to report main outcomes, thus tending to over-
stress the positive results (Table 1, Additional file 1). A
single-centre trial was retrospectively registered in the
ACTRN [42], and one multicentre trial was registered
prospectively in the NTR and retrospectively in the
ACTRN [40]. For this multicentre trial, although the NTR
reported that the trial had stopped, the ACTRN stated
‘still recruiting’, and neither CTR was updated. Two papers
failed to respect the intention-to-treat analysis [29, 40].
Two trials were completed early during a planned interim
analysis by an external Data Safety Monitoring Committee
(DSMC): the first was stopped for efficacy results (more
harm than good in the intervention group), and the target
sample remained unreached, but the ISRCTN failed to re-
port the cause [31], and the second, a multicentre trial,
owing to futility in the results [40], underreported or mis-
reported outcomes in the two registries (NTR and
ACTRN). Published RCT abstracts and results both con-
tained inconsistencies in reporting the reasons for stop-
ping the trials [31, 40]. In another three CTRs and
corresponding RCTs, the five investigator pairs detected a
discrepancy between the primary outcome and efficacy re-
sults reported (more harm than good in the intervention
group) [29, 35, 41]. Three published RCTs underreported
insignificant results [28, 30, 33], one upgrading the sec-
ondary outcome [30], and one downgrading the primary
outcome [33]. Two trials, one registered in the ACTRN
and one in the CTRI, downgraded primary outcome in
the published RCT [33, 41], two upgraded secondary out-
comes, both registered in the NCT [30, 39], and another
eight modified primary outcome or primary outcome
measures, six registered in the NCT, one in ISRCTN, and
one in ACTRN [35–39, 42–44]. For one clinical trial, the
NCT automatically reported the previous RCT paper ref-
erence that included the NCT primary outcome, but
neglected to report the RCT reference that included sec-
ondary outcomes that had been upgraded and yielded in-
significant results [30]. For another clinical trial, the
authors reported their previous published papers in the
NCT record, but neglected to report the second published
RCT giving a partially modified primary outcome in the
updated NCT data, recorded after RCT publication [37].
Of the 20 clinical trials, seven CTRs (three registered in
the NCT, two in the NTR, and two in the ACTRN) failed
to index automatically the RCT reference or Uniform Re-
source Locator (URL) address, and all these trials had dis-
crepancies in outcome data or yielded insignificant results
[28, 33, 34, 37, 38, 40, 42]. Twelve CTRs reported the
RCT references or URL addresses, but the authors failed
to summarise the main results [25–27, 29–32, 35, 36, 39,
43, 44]. For only one clinical trial did the authors report
the main results in the CTRI but neglect to report in-
creased side effects in the intervention group [41] (Table 1,
Additional file 1).
Discussion
By comparing the six reporting domains, mapping, cod-
ing and cross-checking 20 published RCTs with the
matched five CTRs, our study, applied to clinical paedi-
atric trials published in a widely read peer-reviewed jour-
nal, suggests that many trials have discrepancies in
reporting domains. The medium or high combined dis-
crepancy scores we found, when we repeatedly searched
each database online until January 2016, underline major
widely ranging discrepancies between what CTRs record
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Table 1 Clinical trial registry (CTR)-randomised controlled trial (RCT) discrepancies in 20 RCTs scored by assessing and cross-checking inconsistencies in the six reporting domains
identified, assessed and scored according to their importance in a well-conducted triala
Sponsors, funding
and conflict of
interests
incompletely
declared
Discrepant or
unclear sample
size
Inclusion/exclusion
criteria not respected
or selective crossover
Primary outcome or
primary outcome
measure modified
or downgraded or
secondary outcomes
upgraded
Early RCT completion
unjustified
Main
outcome
selectively
reported
or unreported
1 2 3 Combined
discrepancy scores:
low ≤4, medium
5–9, high 10–14b
CTR acronyms,
registration numbers,
and web link for the
20 RCTs published in
the journal Pediatrics
from July to November
2013 (first author and
publication reference)
Cited references
NCT 01351064, URL
https://clinicaltrials.gov
(Carroll et al. 132(3):e623-e
629 Sept 2013)
[25] The RCT incompletely
declared funding
- - - - The CTR automatically
indexed the RCT
reference but the
authors failed to
report the results
Incongruities in the
published RCT
(abstract and results)
4
NCT 01822626, URL
https://clinicaltrials.gov
(Davoli et al.
132(5):e1236-e1245
Oct 2013
[26] - Number of eligible
participants not
provided in the
CTR
- - - The CTR automatically
indexed the RCT
reference but the
authors failed to
report the results
5
ISRCTN 59061709, URL
http://www.isrctn.com/
(McCarthy et al.
132(2):e389-e395
Aug 2013)
[27] - - The RCT failed to
respect the exclusion
criteria for three infants.
During study conduction
one infant crossed over
- - The CTR automatically
indexed the RCT URL
address but the
authors failed to
report the results
5
NTR 1613, URL
www.trialregister.nl
(van der Veek et al.
132(5):e1163-e1172
Nov 2013)
[28] - - Discrepant children’s
age in the inclusion
criteria
- - The CTR failed to
automatically index
the RCT URL address
or reference and the
authors neglected to
report the results. The
published RCT reported
that the intervention
yielded insignificant
results for all endpoints
5
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Table 1 Clinical trial registry (CTR)-randomised controlled trial (RCT) discrepancies in 20 RCTs scored by assessing and cross-checking inconsistencies in the six reporting domains
identified, assessed and scored according to their importance in a well-conducted triala (Continued)
ISRCTN 72635512, URL
http://www.isrctn.com/
(Field et al.
132(5):e1247-e1256
Nov 2013)
[29] - - - - Early study completion
(March 2010 instead of
May 2012)
The CTR automatically
indexed the RCT URL
address but the authors
failed to report the
results. The published
RCT analysed selected
data for randomised
newborns in the
intervention and
control group (80 %
vs 87 %) and reported
an insignificant
statistical difference
for the primary
outcome (cognitive
improvement) but the
authors inadequately
reported more harm
than benefit in the
intervention group for
secondary patient-
centred outcomes
(death, cerebral palsy)
6
NCT 00548379, URL
https://clinicaltrials.gov
(Aluisio et al.
132(4):e832-e840
Oct 2013)
[30] - - Discrepant RCT
inclusion criteria
Secondary outcome
upgraded in the RCT
- The CTR automatically
indexed the RCT
reference including
the CTR primary
outcome but
neglected to report
the RCT including
the secondary
outcome upgraded
and showing an
insignificant statistical
difference between
intervention and
control group
8
ISRCTN 31707342, URL
http://www.isrctn.com/
(McCarthy et al.
132(1): e135-e141
July 2013)
[31] - Discrepancy in
the number of
children enrolled
and analysed (the
CTR failed to
report that an
external Data
Safety Monitor
Committee
stopped the RCT
early hence the
trial failed to reach
the target number
of participants)
- - The updated CTR failed
to report early stopping
after a planned interim
analysis
The CTR automatically
indexed the RCT URL
address but failed to
report early stopping.
The RCT unclearly
reported the reason
for stopping the trial
(more harm than
good for the primary
outcome in the
intervention group)
8
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Table 1 Clinical trial registry (CTR)-randomised controlled trial (RCT) discrepancies in 20 RCTs scored by assessing and cross-checking inconsistencies in the six reporting domains
identified, assessed and scored according to their importance in a well-conducted triala (Continued)
NCT 01307293, URL
https://clinicaltrials.gov
(Shaw et al.
132(4):e886-e894
Oct 2013)
[32] - Discrepancy in the
age of premature
children enrolled
- - Early study completion
(Dec 2012 instead of
Jan 2013)
The CTR automatically
indexed the RCT
reference but the
authors failed to
report the results.
The RCT reported
benefits in the
intervention group
before study
completion date
8
ACTRN 12608000056392,
URL www.anzctr.org.au
(Daniels 132(1):e109- e118
July 2013)
[33] Funding incompletely
declared in the RCT
Discrepancy in the
number of
participants eligible
and enrolled
- Primary outcome
downgraded in the
RCT
- The CTR failed to
automatically index
RCT URL address or
reference and the
authors neglected
to provide results
The RCT failed to
report that the
intervention yielded
insignificant results
9
NCT 00409448, URL
https://clinicaltrials.gov
(Kurowski et al.
132(1):e158-e166
Jul 2013)
[34] Discrepancy in
declared funding
- Discrepant RCT
exclusion criteria
Early study completion
(Jan 2011 instead of
August 2012)
The CTR failed to
automatically index
the RCT URL address
or reference and the
authors neglected to
provide results
9
NCT 00551642, URL
https://clinicaltrials.gov
(Durrmeyer et al.
132(3):e695-e703
Sept 2013)
[35] Funding incompletely
declared in the CTR
- - Primary outcome
completely changed
in the RCT
Published ongoing
study results and
follow-up not
respected
The CTR automatically
indexed the RCT
reference but the
authors failed to
report the results.
The RCT neglected
to report results for
the primary outcome
(more harm than good
in the intervention
group)
10
NCT 01403623, URL
https://clinicaltrials.gov
(Leadford et al.
132(1):e128-e134
Jul 2103)
[36] Funding incompletely
declared in the CTR
- - Primary outcome
measure modified in
the RCT
Early study completion
(Oct 2011 instead of
Dec 2012)
The CTR automatically
indexed the RCT
reference but the
authors failed to
report the results.
Main outcome
measure partially
reported in the RCT
10
NCT 00334737, URL
https://clinicaltrials.gov
(Ohls et al.
132(1):e119-e127
Jul 2013)
[37] Discrepancy in declared
funding
- - Primary outcome
partially modified in
the RCT
Follow-up not respected
(presumably an ongoing
study or randomisation
done for another study)
The CTR reported
previous published
authors’ papers
(2004–2006) but
failed to automatically
10
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Table 1 Clinical trial registry (CTR)-randomised controlled trial (RCT) discrepancies in 20 RCTs scored by assessing and cross-checking inconsistencies in the six reporting domains
identified, assessed and scored according to their importance in a well-conducted triala (Continued)
index the RCT URL
address or reference.
The authors failed to
report results in the
last CTR updated in
November 2013. The
RCT only partially
reported results on
the primary outcome
NCT 01065272, URL
https://clinicaltrials.gov
(Alansari et al.
132(4):e810-e816
Sept 2013)
[38] - - The RCT incompletely
respected inclusion
criteria
Primary outcome
modified in the RCT
Early study completion
(March 2012 instead
of August 2012)
The CTR failed to
automatically index
RCT URL address or
reference and the
authors neglected to
provide results. The
RCT reported results
for the modified
primary outcome
11
NCT 01810978, URL
https://clinicaltrials.gov
(Dilli et al. 132(4):e932-e938
Oct 2013)
[39] - - Discrepancy in the
inclusion criteria
Primary outcome
modified and
secondary outcome
upgraded in the RCT
Early study completion
(Apr 2013 instead of
May 2013)
The CTR automatically
indexed the RCT
reference but the
authors failed to
report the results.
The RCT reported
results for the
modified primary
outcome and
upgraded secondary
outcome
11
NTR 2061 and ACTRN
12610000230055, URLs
www.trialregister.nl and
www.anzctr.org.au
(Kamlin et al.
132(2):e381-e388
Aug 2013)
[40] Funding incompletely
declared in the RCT
Discrepancy in
the number of
participants
eligible and
enrolled
Inclusion criteria
modified in the Dutch
register (NTR) only. The
Australian registry
(ANZCTR), retrospectively
indexed failed to report
inclusion criteria changes
- Australian registry
retrospectively indexed
the trial and failed to
report that the trial
stopped early on an
external data safety
committee decision
(difficulties in recruiting
infants and futility)
The NTR, updated
on 5 Apr 2012, failed
to report completed
results but stated that
the trial was stopped
for slow recruitment
and futility. The
ANZCTR was
retrospectively
registered and not
updated (‘still
recruiting’). The RCT
abstract incompletely
reported that the
external data safety
committee stopped
the trial early owing
to difficulties in
recruiting infants.
Data for 4 children
excluded from the
analysis in the RCT
11
Rosatiet
al.Trials
 (2016) 17:430 
Page
7
of
11
Table 1 Clinical trial registry (CTR)-randomised controlled trial (RCT) discrepancies in 20 RCTs scored by assessing and cross-checking inconsistencies in the six reporting domains
identified, assessed and scored according to their importance in a well-conducted triala (Continued)
CTRI 2010/091/001417,
URL http://ctri.nic.in/Clinicaltrials/login.php
(Malik et al. 132(1):e46-e52
July 2013)
[41] The RCT failed to report
that the trial was used
for a medical thesis
Discrepancy in
the number of
participants
eligible and
enrolled
The RCT reported that
to achieve the final
sample size patients
were enrolled from an
area adjacent to the
setting declared
Primary outcome
downgraded in the
RCT
- The CTR, updated by
the authors on
14 Jun 2012, reported
a brief summary of
positive results for the
downgraded primary
outcome but failed to
report side effects. The
RCT neglected to
report increased side
effects in the
intervention group
11
ACTRN 12612000976886,
URL www.anzctr.org.au
(McIntosh et al.
132(2):326-331
Aug 2013)
[42] - The CTR neglected
to report sample
size
- Primary outcome
measure modified
in the RCT
The CTR was
retrospectively registered
and the RCT failed to
provide completion
date
The retrospectively
registered CTR failed
to automatically index
the RCT URL address
or reference and the
authors neglected to
provide results. The
RCT only partially
reported results on
the primary outcome
11
ISRCTN 03981121, URL
http://www.isrctn.com/
(Wake et al.
132(4):e895-e904
Oct 2013)
[43] - Discrepancy in
the number of
participants
eligible and
enrolled
- Primary outcome
measure modified
in the RCT
No study conduction
period specified in the
RCT. Results reported
for only half of the
declared follow-up
The CTR automatically
indexed the URL
address of the
published RCT. The
RCT neglected to
report results for the
primary outcome
(no statistical
difference) but
reported a significant
difference for a
secondary outcome
11
NCT 01604460, URL
https://clinicaltrials.gov
(Belsches et al.
132(3):e656-e661
Sept 2013)
[44] Discrepancy in
declared funding
- The RCT reported a
modified intervention
procedure for the
included infants
Discrepancy in primary
outcome measures
Early study completion
(June 2012 instead of
November 2012)
The CTR automatically
indexed the URL
address of the
published RCT, but
the authors failed
to report results.
The RCT only partially
reported results on
the primary outcome
12
aReporting domains chosen from our clinical experience in critically appraising RCTs and the Cochrane Collaboration tool for assessing risk of bias (main outcome selectively reported or unreported) [23, 24]. Upgrading
secondary outcomes means reporting secondary outcomes as primary outcomes in the publication. Discrepancies in the domain ‘main outcome selectively reported or unreported’ had similar scores because
inconsistencies in this domain could have made the RCT results untrustworthy or less trustworthy. CTR abbreviations: the United States National Institute of Health (NCT), the International Standard Randomised
Controlled Trial Number (currently BioMed Central Open Access publishers) (ISRCTN), the Nederlands Trials Register (NTR), the Australian and New Zealand Clinical Trial Registry (ACTRN), and the Clinical Trial Registry-India
(CTRI). Trials are listed and grouped according to the combined discrepancy scores. When scores are identical, trials are listed alphabetically by first author surnames. bHigher discrepancy scores suggest risk of bias
CTR clinical trial registry, RCT randomised controlled trial, URL Uniform Resource Locator
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and what published paediatric RCTs then report. The
discrepancies we identified in declaring funding and
conflict of interests in nine trials, in the number of eli-
gible and enrolled participants in eight clinical trials and
in another nine inclusion and exclusion criteria not
being respected, emphasise the generally imperfect
reporting. These major discrepancies, especially those
involving changes in the original study hypotheses, trial
designs, study conduction and reporting outcomes raise
concern on trustworthiness in scientific trials, as previ-
ous papers have underlined [5–9, 13, 15, 16].
Surprisingly, of the 20 published RCTs 11 modified or
downgraded primary outcomes or upgraded secondary
outcomes (reported secondary outcomes as primary out-
comes in the publication), misreporting or tending to
overstress positive results. This discrepancy underlines
concerns about trial creditability that the CASP checklist
overlooks. By assessing and scoring CTR-RCT discrep-
ancies in six clinical trial reporting domains, our study
therefore expands current knowledge, thus emphasising
the need for international clinical trial regulators to
make publicly available CTR-RCT discrepancies in
published RCT findings, as recently underlined by the
WHO Statement on public disclosure of clinical trial re-
sults (http://www.who.int/ictrp/results/reporting/en/; last
accessed 20 January 2016). For example, trial (number 5
in Table 1) [29] addresses as primary outcome cognitive
improvement and provides significant statistical difference
between the intervention and control groups, but leaves
unaddressed clinically important patient-centred out-
comes, such as deaths and cerebral palsy. Even though
deaths increased and cerebral palsy doubled in the inter-
vention group, in their conclusions the investigators para-
doxically report that ‘nonsignificant trends in the data
suggested a small adverse effect’. In another trial (number
7 in Table 1) [31] an external DSMC decided to stop RCT
completion early owing to hyperthermia in the infants en-
rolled in the intervention group. Neither the highlights
section in the RCT nor the conclusions report this result.
Although the published RCT reports when the trial
stopped, our findings disclose an important clinically rele-
vant feature, namely more harm than good for the pri-
mary outcome in the intervention group.
Another unexpected discrepancy in a multicentre trial
(number 16 in the Table 1) [40] was that the authors in-
appropriately and unclearly reported that an external
DSMC stopped the trial for futility. The numerous CTRs
updated only by dataset supervisors (URL or RCTs refer-
ence cited in 12/20 trials), and failing to report results
(7/20 trials) underline discrepancies involving incom-
pletely and selectively reported clinical outcome results
[5, 45–47]. This finding, along with underappreciated
core patient-centred outcomes, raises ethical con-
cerns and suggests dissemination or reporting bias
[45–49]. Even though the journal Pediatrics complies
with ICMJE requirements [11], and authors are re-
quired to submit a completed flowchart and checklist
for the CONSORT statement [12] before publication
(http://www.aappublications.org/content/pediatrics-author-
guidelines#acceptance_criteria; last accessed 20 January
2016), and all the 20 published RCTs give the trial registra-
tion number on the first page, our findings underline that
still today few authors endorse these rules [13, 14, 17].
An unexpected finding concerned prospective trial
registration [11]. Although our study design did not re-
quire us to check clinical trial registration timing, we de-
tected two trials (numbers 16 and 18 in Table 1) [40, 42]
that had been registered retrospectively and failed to
comply with ICMJE registration requirements. One of
these two, a multicentre RCT (number 16 in Table 1)
[40], was registered prospectively in the NTR and retro-
spectively in the ACTRN, and although the NTR re-
ported that the trial had stopped for futility, the ACTRN
stated ‘still recruiting’ Because a retrospectively regis-
tered trial could be hard to identify, regulators need to
find new ways to encourage researchers to update infor-
mation in a timely manner [50–52].
Most important, the major discrepancies our study
highlighted in paediatric clinical trials give new clinically
important information that researchers synthesising evi-
dence from published RCTs in scientific literature re-
views could fail to identify without cross-checking
CTRs. Hence, they could provide less reliable scientific
evidence, and misdirect future research priorities [49–53].
Our findings could also alert medical journals on the need
to introduce rules that require investigators to submit the
original Institutional Review Board-approved protocol
(and its subsequent amended versions), and to explain
later changes, thus helping reviewers and editors in decid-
ing whether to publish the trial and what the final manu-
script should state.
Limitations
We acknowledge that our study has several limitations.
Because we applied our study method only in few unse-
lected consecutive paediatric RCTs published in a major
paediatric journal, rather than including other authorita-
tive journals with higher impact factors, our findings re-
quire further validation. Even though our scoring for
reporting domains needs further refinement, our find-
ings should make it easier for physicians to use research
results from clinical trials. Because most authors
neglected to update CTRs, we were unable to seek dis-
crepancies in what authors recorded in CTRs and re-
ported in published RCTs by cross-checking clinical
outcome results. Similarly, because none of the five
CTRs recorded or the cross-checked matched 20 RCTs
appraised gave the necessary information, nor were we
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able to assess data for patient nonresponse and refusal.
Although we analysed a small RCT sample, we found no
differences in combined CTR-RCT discrepancy scores
among the various CTRs. A final limitation is that we
failed to assess interobserver reliability for the different
assessor times for individual items and combined CTR-
RCT discrepancy scores.
Conclusions
Our study identifies major discrepancies between what
CTRs record and paediatric RCTs publish. Our findings
should make clinicians who rely on RCT results for
medical decision-making, aware of dissemination or
reporting bias. Trialists need to bring CTR data and re-
ported protocols in line with published data. Clinical re-
searchers and reviewers could search for CTR-RCT
discrepancies to cross-check inconsistencies in core clin-
ical trial reporting domains. Medical journals need to
introduce rules that require investigators to submit the
original Institutional Review Board-approved protocol
(and its subsequent amended versions), and to explain
any discrepancies. Assessing discrepancies would with
little effort provide greater transparency, avoid wasting
research resources, and encourage those who prepare
medical recommendations and guidelines to think more
critically. Future studies need to clarify whether the trial
discrepancies we report warrant scepticism regarding
study validity, or call for trialists to be more diligent
about updating CTR data.
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